DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2098
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/cancers12082098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide receptor radionuclide therapy: Looking back, looking forward.
- (2020) Danny Feijtel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy
- (2020) Edward O'Neill et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy
- (2020) Damien Carignan et al. PROSTATE
- Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
- (2020) Stergios Boussios et al. Drugs in research & development
- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- Radiotherapy toxicity
- (2019) Dirk De Ruysscher et al. Nature Reviews Disease Primers
- Treatment: the role of contact X-ray brachytherapy (Papillon) in the management of early rectal cancer
- (2019) A. Sun Myint et al. Colorectal Disease
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair
- (2019) Eirini Terpsi Vitti et al. Cancers
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
- (2019) Jacqueline H. L. Fok et al. Nature Communications
- The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
- (2019) Eline A.M. Ruigrok et al. Pharmaceutics
- Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?
- (2019) Alice Bradbury et al. PHARMACOLOGY & THERAPEUTICS
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells
- (2018) Hilal Taymaz-Nikerel et al. Scientific Reports
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
- (2017) Andrew N. Blackford et al. MOLECULAR CELL
- Synthetic lethality screens point the way to new cancer drug targets
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Synthetic lethality and cancer
- (2017) Nigel J. O'Neil et al. NATURE REVIEWS GENETICS
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Recent Developments in Radiotherapy
- (2017) Deborah E. Citrin NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- Replication-Dependent Unhooking of DNA Interstrand Cross-Links by the NEIL3 Glycosylase
- (2016) Daniel R. Semlow et al. CELL
- Science in Focus: Combining Radiotherapy with Inhibitors of the DNA Damage Response
- (2016) A.J. Chalmers CLINICAL ONCOLOGY
- Measurement of complex DNA damage induction and repair in human cellular systems after exposure to ionizing radiations of varying linear energy transfer (LET)
- (2016) Zacharenia Nikitaki et al. FREE RADICAL RESEARCH
- Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy
- (2015) L.J. Forker et al. CLINICAL ONCOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- BRACAnalysis CDx as a companion diagnostic tool for Lynparza
- (2015) Camille C Gunderson et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mechanisms and Consequences of Double-Strand DNA Break Formation in Chromatin
- (2015) Wendy J. Cannan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The current state of eukaryotic DNA base damage and repair
- (2015) Nicholas C. Bauer et al. NUCLEIC ACIDS RESEARCH
- The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
- (2015) G. K. Pennock et al. ONCOLOGIST
- Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition
- (2015) Fiona K. Middleton et al. Oncotarget
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
- (2014) K. A. T. Naipal et al. CLINICAL CANCER RESEARCH
- Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
- (2014) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Entering the mainstream of cancer treatment
- (2014) Steven A. Rosenberg Nature Reviews Clinical Oncology
- Understanding nucleotide excision repair and its roles in cancer and ageing
- (2014) Jurgen A. Marteijn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- Biological Consequences of Radiation-induced DNA Damage: Relevance to Radiotherapy
- (2013) M.E. Lomax et al. CLINICAL ONCOLOGY
- Topoisomerase inhibitors as anticancer agents: a patent update
- (2013) Daulat B Khadka et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States
- (2013) Kathy Han et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel
- (2013) Y. Maede et al. MOLECULAR CANCER THERAPEUTICS
- Base Excision Repair
- (2013) H. E. Krokan et al. Cold Spring Harbor Perspectives in Biology
- Review article Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
- (2013) Janusz Skowronek Journal of Contemporary Brachytherapy
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
- (2012) Michael S. Glickman et al. CELL
- A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors
- (2012) A. Rajan et al. CLINICAL CANCER RESEARCH
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy Beam
- (2012) Richard. A. Britten et al. RADIATION RESEARCH
- Prodrugs for improving tumor targetability and efficiency
- (2011) Rubi Mahato et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparison of cellular damage response to low-dose-rate 125I seed irradiation and high-dose-rate gamma irradiation in human lung cancer cells
- (2011) Honghong Chen et al. Brachytherapy
- Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair
- (2011) Blanka Sengerová et al. CELL CYCLE
- ATR–Chk1 signaling pathway and homologous recombinational repair protect cells from 5-fluorouracil cytotoxicity
- (2011) Yoshihiko Fujinaka et al. DNA REPAIR
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- Clinical radioimmunotherapy—the role of radiobiology
- (2011) Jean-Pierre Pouget et al. Nature Reviews Clinical Oncology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells
- (2011) Nicolaas Franken ONCOLOGY REPORTS
- Radioembolization for Primary and Metastatic Liver Cancer
- (2011) Khairuddin Memon et al. SEMINARS IN RADIATION ONCOLOGY
- High-Dose-Rate Prostate Brachytherapy
- (2010) Alvaro A. Martinez et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization
- (2010) Ahsun Riaz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination
- (2010) Marcelo de Campos-Nebel et al. PLoS One
- Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy
- (2010) Sebastian Lettmaier et al. RADIOTHERAPY AND ONCOLOGY
- Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer
- (2009) William B. Parker CHEMICAL REVIEWS
- Coordination of DNA Mismatch Repair and Base Excision Repair Processing of Chemotherapy and Radiation Damage for Targeting Resistant Cancers
- (2009) T. J. Kinsella CLINICAL CANCER RESEARCH
- Nuclisome: a novel concept for radionuclide therapy using targeting liposomes
- (2009) Amelie Fondell et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Damage, Aging, and Cancer
- (2009) Jan H.J. Hoeijmakers NEW ENGLAND JOURNAL OF MEDICINE
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Participation of DNA repair in the response to 5-fluorouracil
- (2008) M. D. Wyatt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interplay of two major repair pathways in the processing of complex double-strand DNA breaks
- (2008) Tracey A. Dobbs et al. DNA REPAIR
- Resistance mechanisms to cancer chemotherapy
- (2008) Kelly Marie Redmond Frontiers in Bioscience-Landmark
- Therapeutic Radionuclides: Biophysical and Radiobiologic Principles
- (2008) Amin I. Kassis SEMINARS IN NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now